Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes (DIABESITY)

Novo Nordisk

Status: Completed

Conditions: Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: insulin detemir

Study type: Observational

Funder types: Industry

Identifiers

NCT00687063

NN304-3530

Details and patient eligibility

About

The study is conducted in Asia. The aim of this observational study is to evaluate the weight change from baseline while using Levemir® in subjects with type 2 diabetes mellitus under normal clinical practice conditions in India.

Enrollment: 10,008 patients

Sex: All

Ages: 6+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any subject with type 2 diabetes

Exclusion criteria

• Subjects with a hypersensitivity to insulin detemir or any of its excipient
• Children below 6 years
• Subjects who are pregnant, lactating or planning to become pregnant

Trial design

10,008 participants in 1 patient group

A

Treatment:

Drug: insulin detemir